Evaluation of individualized interventional therapies for patients with unresectable intrahepatic cholangiocarcinoma

• Conditions: C22.1; Intrahepatic bile duct carcinoma

• Registration Number: DRKS00006237
• Lead Sponsor: niversitätsklinikum Magdeburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2014-03-30
• Study Start: 2014-06-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

Patients with inoperable iCC
- indication for interventional therapy
- complete therapy and follow-up

Exclusion Criteria

a) Karnofsky < 60%
b)Cancer of unknown primary
c)second malignancy
d)incomplete Follow-up

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival

Secondary Outcome Measures

Name	Time	Method
factors influencing survival